437 related articles for article (PubMed ID: 16723576)
21. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.
Chen CJ; Huang YC; Chiu CH
J Antimicrob Chemother; 2015 Nov; 70(11):2965-72. PubMed ID: 26216581
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
[TBL] [Abstract][Full Text] [Related]
23. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
[TBL] [Abstract][Full Text] [Related]
24. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR.
Kato Y; Suzuki T; Ida T; Maebashi K
J Antimicrob Chemother; 2010 Jan; 65(1):37-45. PubMed ID: 19889788
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin.
Su J; Iehara M; Yasukawa J; Matsumoto Y; Hamamoto H; Sekimizu K
J Antibiot (Tokyo); 2015 Oct; 68(10):646-8. PubMed ID: 25899124
[No Abstract] [Full Text] [Related]
29. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
[TBL] [Abstract][Full Text] [Related]
30. Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome.
Yamaguchi T; Suzuki S; Okamura S; Miura Y; Tsukimori A; Nakamura I; Ito N; Masuya A; Shiina T; Matsumoto T
Antimicrob Agents Chemother; 2015; 59(6):3585-7. PubMed ID: 25779584
[TBL] [Abstract][Full Text] [Related]
31. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
Cui L; Tominaga E; Neoh HM; Hiramatsu K
Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
33. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
Skiest DJ
J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
[TBL] [Abstract][Full Text] [Related]
34. Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.
Sorlozano A; Gutiérrez J; Roman J; Liebana J; Piedrola G
Microb Drug Resist; 2009 Jun; 15(2):125-7. PubMed ID: 19432525
[TBL] [Abstract][Full Text] [Related]
35. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
36. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
37. Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus.
Quinn B; Hussain S; Malik M; Drlica K; Zhao X
J Antimicrob Chemother; 2007 Dec; 60(6):1380-3. PubMed ID: 17905797
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains.
Diederen BM; van Duijn I; Willemse P; Kluytmans JA
Antimicrob Agents Chemother; 2006 Sep; 50(9):3189-91. PubMed ID: 16940127
[TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
Jevitt LA; Thorne GM; Traczewski MM; Jones RN; McGowan JE; Tenover FC; Brown SD
J Clin Microbiol; 2006 Sep; 44(9):3098-104. PubMed ID: 16954233
[TBL] [Abstract][Full Text] [Related]
40. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
